9:48 a.m. ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. Moderna said Wednesday that its flu vaccine, mRNA-1010, met its primary endpoint in a recent late-stage trial. The data were released as the company works toward expanding its pipeline now that Covid-19 vaccine demand decreases. The company also said it was cutting back on its prior estimate of the size of the U.S. commercial Covid-19 vaccine market. Dow Jones & Co. owns Factiva. (chris.wack@wsj.com)

(END) Dow Jones Newswires

September 13, 2023 10:04 ET (14:04 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Moderna.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Moderna.